A growing measles outbreak in the Philippines killed at least 25 people last month, officials said Thursday, putting some of the blame on mistrust stoked by a scare over an anti-dengue fever vaccine. Most of the dead are children and the toll is expected to ...
Bypassing U.S. regulators, Takeda takes its dengue shot to the tropics first
A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year. Takeda Pharmaceutical Co. plans to seek approval for the experimental vaccine first in countries where the virus is endemic, ...
Takeda dengue vaccine meets main goal of trial; detailed results to come
Takeda Pharmaceutical Co. said Tuesday that its experimental dengue vaccine appears to be safe and effective at preventing all four types of the mosquito-borne disease, meeting the main goal of the drugmaker's late-stage clinical trial. The company said no significant safety concerns have emerged to ...
Philippines snubbed advice of experts to tread incrementally in pursuing child dengue immunizations
As she announced in January 2016 that the Philippines would immunize 1 million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research. At the time, it seemed ...
U.S. Army, France's Sanofi to speed effort to develop Zika vaccine
French drugmaker Sanofi said on Wednesday it had struck a research and development deal with the U.S. Army to speed up the development of a vaccine against the mosquito-borne Zika virus. Sanofi is the only major drugmaker working on a vaccine against Zika, which has ...
Japanese drugmaker SSP Co. will be put under the wing of Sanofi as the French health care titan and Germany's Boehringer Ingelheim GmbH announced an asset swap agreement Monday. Under the deal, Sanofi will acquire Boehringer's consumer health operation, including SSP, in exchange for its ...
Zika poses Asia, Oceania, South Europe threat; Sanofi joins race for viable vaccine
The Zika virus could spread to Africa, Asia and Southern Europe, the World Health Organization said on Tuesday, as major French drugmaker Sanofi SA and others joined the race to create a vaccine. A day after Geneva-based WHO declared an international public health emergency due ...
Mexico approves world's first dengue vaccine after 20 years of research
The first vaccine against dengue fever won clearance in Mexico, an initial step toward preventing a mosquito-borne infection that puts half of the world's population at risk. Sanofi expects more approvals in "upcoming weeks" for the product, called Dengvaxia, in Latin America and Asia, Olivier ...
Highly anticipated cholesterol drug gets FDA panel's qualified nod
Federal health advisers on Tuesday recommended approval for a highly anticipated cholesterol drug from Sanofi and Regeneron Pharmaceuticals, but with the caveat that more data are needed about its long-term ability to reduce heart attacks. The expert panel recommended by a 13-3 vote that the ...
Mosquito-borne dengue targeted by antibody with hope for vaccine
Scientists have discovered new antibodies that neutralize viruses that cause dengue, potentially putting a universal vaccine within reach for a mosquito-borne illness that strikes an estimated 400 million people a year. The antibodies are effective against all four dengue viruses, according to an article published ...
